Travere Therapeutics Inc. (TVTX)
NASDAQ · Healthcare
Travere Therapeutics Inc. Net Income 2011–2025
Travere Therapeutics Inc. annual/quarterly net income history and growth rate from 2011 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Travere Therapeutics Inc. net income for the quarter ending March 31, 2026 was -37.1 M, a 10.00% decrease year-over-year.
- Travere Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -65.4 M, a 40.86% decrease year-over-year.
- Travere Therapeutics Inc. annual net income for 2025 was -25.5 M, a 92.06% decrease from 2024.
- Travere Therapeutics Inc. annual net income for 2024 was -321.5 M, a 188.64% increase from 2023.
- Travere Therapeutics Inc. annual net income for 2023 was -111.4 M, a 60.00% decrease from 2022.
- Travere Therapeutics Inc. annual net income for 2022 was -278.5 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Travere Therapeutics Inc. Net Income — FAQ
Travere Therapeutics Inc. (TVTX) net income over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
What is Travere Therapeutics Inc.'s net income?
Travere Therapeutics Inc. (TVTX) reported net income of -$26M for fiscal 2025.
Where can I see TVTX's net income history?
The chart and table above show Travere Therapeutics Inc.'s net income by year and by quarter, including the growth rate.